Molecular Docking Analysis of Piperonal and its Analogues as Promising Cancer Therapeutics by Modulating Angiogenesis
Abstract
Cancer is an emerging disease that pose severe public health problem that has a poor prognosis at early stage encompassing small number of effective therapies leading to high mortality rate at an alarming rate. The cancer cell multiplication and growth can be arrested at an early metastasis stage by inhibiting VEGF involved in angiogenesis. Hence in the present study, insilico approach is followed to screen piperonal and its significant analogues for inhibitory role against VEGF. The molecular properties were analysed using Molinspiration and molecular docking analysis was performed using Glide Schrodinnger. The compounds tenamfetamine and midomafetamine showed better binding strength when compared with Sorafenib.
Keywords: Piperonal, Structural Analogues, Angiogenesis, Metastasis, VEGF, Molecular docking, Autodock.
Keywords:
Piperonal, Structural Analogues, Angiogenesis, Metastasis, VEGF, Molecular docking, AutodockDOI
https://doi.org/10.22270/jddt.v13i7.5917References
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990 - 2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017; 390:1221-59.
Gupta K, Zhang J. Angiogenesis: a curse or cure? Postgrad Med J. 2005; 81(954):236-42. https://doi.org/10.1136/pgmj.2004.023309
Adair TH, Montani JP. Angiogenesis. San Rafael (CA): Morgan & Claypool Life Sciences; 2010. Chapter 1, Overview of Angiogenesis. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53238/ https://doi.org/10.4199/C00017ED1V01Y201009ISP010
Adair TH, Montani JP. Angiogenesis. San Rafael (CA): Morgan & Claypool Life Sciences; 2010. Chapter 3, Regulation: Metabolic Factors. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53243/
Adair TH, Montani JP. Angiogenesis. San Rafael (CA): Morgan & Claypool Life Sciences; 2010. Chapter 4, Regulation: Mechanical Factors. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53240/ .
Rizov, M.; Andreeva, P.; Dimova, I. Molecular regulation and role of angiogenesis in reproduction. Taiwan. J. Obstet. Gynecol. 2017; 56:127-132. https://doi.org/10.1016/j.tjog.2016.06.019
Augustine, R.; Prasad, P.; Khalaf, I.M.N. Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions. Mater. Sci. Eng. C 2019; 97:994-1008. https://doi.org/10.1016/j.msec.2019.01.006
Guerra, A.; Belinha, J.; Jorge, R.N. Modelling skin wound healing angiogenesis: A review. J. Theor. Biol. 2018; 459:1-17. https://doi.org/10.1016/j.jtbi.2018.09.020
Zhao Y., Adjei A.A. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Oncologist. 2015; 20: 660-673. https://doi.org/10.1634/theoncologist.2014-0465
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. https://doi.org/10.1016/j.cell.2011.02.013
Heath VL, Bicknell R. Anticancer strategies involving the vasculature. Nature Reviews Clinical Oncology. 2009; 6(7):395-404. https://doi.org/10.1038/nrclinonc.2009.52
Cesca M, Bizzaro F, Zucchetti M, Giavazzi R. Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents. Frontiers in Oncology. 2013; 3:259. https://doi.org/10.3389/fonc.2013.00259
Fuso Nerini I, Cesca M, Bizzaro F, Giavazzi R. Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics. Chinese Journal of Cancer. 2016; 35:61. https://doi.org/10.1186/s40880-016-0123-1
Ashwin Prakash Karurkar, Anuradha Venkatraman, Syed Ali Mohammed Yacoob, Asrar Ahmed, Mohamed Sihabudeen. Chemically synthesized Schiffs base Conjugated Piperonal as novel Antioxidants and Scavengers of Free Radicals. Research Journal of Pharmacy and Technology. 2022; 15(11):4887-3. https://doi.org/10.52711/0974-360X.2022.00838
Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2023 update. Nucleic Acids Res. 2023 Jan 6; 51(D1):D1373-D1380. https://doi.org/10.1093/nar/gkac956 https://pubchem.ncbi.nlm.nih.gov/ .
Du J, Sun H, Xi L, Li J, Yang Y, Liu H, Yao X, Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation. J Comput Chem 2011; 32(13):2800-2809. https://doi.org/10.1002/jcc.21859
Published
Abstract Display: 383 
PDF Downloads: 613 PDF Downloads: 328 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.